Interim no more: Ashley Magargee to fill Genentech CEO post; Pfizer, Moderna make commercial leadership adjustments
Ashley Magargee will become the CEO of Genentech on Jan. 1, two decades into her tenure at the South San Francisco …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.